Mubasher: Germany is trying to prevent the US from monopolising any future coronavirus vaccine after President Donald Trump offered funds to a German company working on a vaccine against the new COVID-19 virus to move its research to the US, Reuters reported.
Germany’s health ministry affirmed a report published by local press that the US has attempted to convince Germany’s CureVac to move its research on a vaccine against the new coronavirus to the US, a spokeswoman for the German ministry told Reuters.
“The German government is very interested in ensuring that vaccines and active substances against the new coronavirus are also developed in Germany and Europe. In this regard, the government is in intensive exchange with the company CureVac,” according to a statement by a ministry official quoted by Welt am Sonntag.
However, the US Embassy in Berlin and CureVac have not made any comments regarding the news.